SAN DIEGO, CA, June 16, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company"), a leading innovator of payment transaction solutions leveraging electronic payment technology, has appointed industry veteran Brett Moyer as an independent member of its board of directors, effective immediately. “I’m delighted to welcome Brett Moyer to our board,” said RYVYL Co-founder and Chairman Ben Errez. “Brett’s experience in building companies and proven expertise in scaling and licensing technolog ...

MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to initiate a Phase 2/3 pivotal confirmatory trial of OCU410ST, a modifier gene therapy candidate being developed for all Stargardt disease (ABCA4-associated retinopathies). The FDA previously granted Rare Pediatr ...

USAR to Qualify its Magnets for use in Moog’s CoreMotion™ Liquid Coolant Distribution PumpsSTILLWATER, Okla., June 16, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company) today announced it has signed a memorandum of understanding (MOU) with Moog Electric Motion Solutions (Moog) for delivery of the Company’s neo magnets, of which USAR plans to begin production in early 2026. Moog Electric Motion Solutions provides precision motion and fluid control systems and will begin proto ...

ZUG, Switzerland, June 16, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced a summary of data that were presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025. “Pharvaris embraced ...

Announcement marks the third phase of USD 100 million share buyback program Dubai, June 16, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), announces that it will shortly commence the third phase of its previously announced share buyback program with respect to the Company’s American Depositary Shares (“ADSs”). This third phase of the buyback will be in the amount of up to USD 35 million. The third phase of the share buyback program is being launched after the successf ...

MIAMI BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS), a national provider of premium body contouring procedures, today announced the voluntary prepayment of $10.0 million of its outstanding term loan debt using cash on hand, following the successful completion of its offering of 3,634,000 shares of common stock, which generated net proceeds, after estimated expenses, of approximately $13.8 million. The Company noted that with this financing and assum ...

Castellum Announces Closing of $5.0 Million Public Offering of Common Stock and Warrants Castellum, Inc. (the “Company” and “Castellum”) (NYSE-American: CTM) today announced the closing of its previously announced public offering of 4,166,667 Units at a public offering price of $1.20 per Unit - www.castelumus.com VIENNA, Va., June 16, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (the “Company” and “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused o ...

With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499/month or less, regardless of insurance status, under Zepbound Self Pay Journey ProgramIn a clinical trial, adults with obesity or overweight and a weight-related medical condition taking Zepbound 15 mg lost 48 lbs (~21% weight loss) and approximately 1 in 3 on Zepbound 15 mg lost over 58 lbs (25% weight loss)INDIANAPOLIS, June 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) ...

TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. (“Blue Moon” or the “Company”) (TSXV: MOON; OTCQX: BMOOF), is pleased to announce that the company has commenced underground construction on the Nussir Mine completing the first blast on the access portal on June 12, 2025; ahead of schedule. Nussir’s mining contractor, Leonhard Nilsen & Sonner AS (“LNS”) will extend the decline approximately 2,500 meters providing a platform for further underground exploration. The exploration work to be compl ...

Group 1 - Subsea 7 S.A. will publish its second quarter 2025 results on 31 July 2025 at 08:00 CET [1] - A conference call and webcast for the investment community will take place on the same day at 11:00 UK / 12:00 CET [1] - The results announcement and presentation will be available on the Subsea 7 website from 08:00 CET [1] Group 2 - Conference call registration can be done via a provided phone link and webcast link [2] - Questions during the conference call can only be submitted from a phone line [2] - Subsea 7 focuses on delivering offshore energy transition solutions [2]